Fera Pharmaceuticals Announces Launch of Moxatag® Authorized Generic

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NEW YORK--(BUSINESS WIRE)--Fera Pharmaceuticals is pleased to announce that it has been selected by Pragma Pharmaceuticals to launch Amoxicillin Extended-Release Tablets, the authorized generic for Moxatag®.

Craig Salmon, VP of Sales at Fera says, “By having an authorized generic available, it is our hope that more patients will gain access to this once-a-day antibiotic therapy helping to ensure greater adherence and compliance.”

Hey, check out all the engineering jobs. Post your resume today!

Back to news